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1. Introduction 
Amenorrhea and menorrhagia are opposites and not in any way related to each other. 
However, the main goal of endometrial ablative therapy in menorrhagia is to establish 
amenorrhea. Therefore, it is obvious that we spend some words on this subject. 
Menorrhagia is an important problem in premenopausal women visiting their 
gynaecologist or general practitioner. Treatment of menorrhagia is diverse: oral 
contraceptives, intra-uterine hormone devices, hysterectomy, or, endometrial ablation. 
The latter has proved itself as a valuable technique which is fast, minimal invasive and 
cost-effective without need for hospitalisation. In this chapter we will discuss the history, 
the different techniques, indications and complications and some special features of 
endometrial ablation.  
2. History 
Heavy menstrual bleeding or menorrhagia affects approximately 20% of all healthy 
premenopausal women aged 30-49 (Vessey, 1992), causing anaemia and/or a decrease in 
quality of life. It is a widespread problem and approximately 12% of all referrals to a 
gynaecologist are related to heavy menstrual bleeding.  
First step in treatment is medical therapy, that is to say oral contraceptives. The efficiency of 
this therapy is variable and the best result with an optimal medicamental treatment is about 
50% reduction of the amount of blood loss (EHC, 1992). The levonorgestrel-releasing 
intrauterine system is more effective and reduces heavy menstrual bleeding in 94% (Irvine, 
1998). However, many women prefer a non-hormonal treatment when the conservative 
treatment with oral contraceptives or a levonorgestrel-releasing system is not sufficient. In 
this group of patients sometimes surgical therapy is indicated. For decades hysterectomy 
was the only surgical treatment. Although very effective, hysterectomy involves significant 
physical implications, a high price in both social and economic costs, a high rate of major 
and minor post-operative complications and a long recovery time.  
Targeted endometrial destruction was originally developed and published in 1936 by 
Bardenheuer (Bardenheuer, 1937), using a radiofrequency electrosurgical probe passing 
through the cervical canal into the endometrial cavity without endoscopic guidance. 
Another technique, was developed in 1967 by Cahan and Brockunier (Cahan and 
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Brockunier, 1967), called cryoendometrial ablation. They used a probe, also without 
endoscopic guidance, cooling the endometrial lining. Both techniques did not become 
widely adopted and the use of endometrial ablation was limited until the introduction of 
hysteroscopy. After 1980, a new less invasive, uterine sparing method, the hysteroscopic 
endometrial ablation was developed. The first techniques described were the laser ablation, 
transcervical endometrial resection (TCRE) and rollerball endometrial ablation. The aim of 
all three techniques was to remove, or destroy the entire thickness of the uterine 
endometrial lining and the basal endometrial glands present in the superficial myometrium. 
These techniques were all hysteroscopic, performed under general anaesthesia and 
requiring good surgical skills for the best therapeutic effect. These techniques, referred as 
the first generation, are intensively studied and became the gold standard for endometrial 
ablation in treatment of heavy menstrual bleeding. Compared to medicamental treatment 
the results of these techniques were much better but obviously less effective than 
hysterectomy. However, patient satisfaction is high and complication rate is lower 
compared to hysterectomy (Abbot, 2002).  
With ongoing development, a new generation of minimal invasive techniques without the 
need of the typical surgical skills of the first generation, was born: the so called second 
generation endometrial ablation. The main difference between the first and second 
generation techniques is the absence of the hysteroscopy. This makes the technique easier to 
perform, with a lower risk of complications and without the need for skilled surgeons. 
Although a whole number of methods are taken together and called the second generation, 
in reality it is a wide variety of different techniques: the hot liquid balloons, the microwave, 
bipolar ablation, phototherapy and chemical destruction of the endometrial lining. With the 
development of the second generation, operation time and hospitalisation became shorter, 
with a lower need for complimentary surgery following non satisfactory treatment and a 
higher satisfactory rate (Lethaby, 2009).  
3. Endometrial ablation techniques 
The development of endometrial destruction techniques starts around 1937 as mentioned 
before. For long time the idea of endometrial destruction was leaved. During the eighties 
of previous century, the idea was revived due to new techniques and insights from other 
medical specialities, especially the urologists.After that period the development of the 
techniques was a bit faster and is going on till today. Table 1. summarizes the available 
techniques.  
3.1 First generation techniques 
3.1.1 Laser 
In 1981 Milton Goldrath introduced the first hysteroscopically assisted photo vaporisation of 
the endometrium (Goldrath, 1981). They used a device that could be introduced through the 
instrument channel of an operating hysteroscope. The method he used was a Neodymium: 
Yttrium Alumnum Garnet laser, (Nd:YAG). Because of the high costs and the development 
of new hysteroscopic techniques, gynaecologists collectively replaced the heavy and 
expensive technique of laser ablation by the resectoscope. These newer methods, influenced 
by the resectoscope of the urologist, were adopted worldwide.  
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Endometrial destruction techniques.  
Hysteroscopic: 
 Nd:YAG laser 
 Electorsurgical rollerbal 
 Transcervical resection. 
Non hysteroscopic:  
 Balloon thermal ablation 
 CavatermTM plus 
 Thermachoice® 
 Thermablate® 
 Menotreat® 
 Free fluid thermal ablation 
 Hydro Thermablate® 
 Microwave ablation 
 MEA® 
 Bipolar radiofrequency ablation 
 Novasure® 
 Cryotherapy 
 HerOption® 
Other: 
 Endometrial laser intrauterine 
thermal therapy: ELITT 
 Gynelease® 
 Chemoablation 
 Photodynamic ablation 
Table 1. Endometrial destruction techniques. 
3.1.2 Electrosurgical rollerball and transcervical resection of the endometrium 
Inspired by the results and knowledge of the urologic resections, new techniques were 
invented to replace the laser photo vaporisation of the endometrium. The resectoscope that 
was developed could pass through the instrument channel of an operating hysteroscope. 
With this loop shaped monopolar electro coagulating assisted resectoscope endometrium 
can be removed from the entire endometrial cavity (Decherney, 1987). The electrosurgical 
rollerball is also a hysteroscopic monopolar technique, with the difference that it is not 
resecting, but only coagulating the endometrial lining. Both methods could be and are often 
combined in the same session.  
3.2 Second generation techniques 
The difficulties experienced with the first generation paved the way to develop new 
techniques without a need for typical surgical skills and without the complications 
associated with the hysteroscopic technique. Although these newer methods do not require 
direct visualisation of the endometrium by hysteroscopy, they are mutually different, using 
either heat or cold, microwave or radiofrequency energy. Compared to the first generation 
the complication rates are lower, operation time is shorter and some of these techniques can 
be applied in an outpatient setting. Their effectiveness and safety are intensively studied 
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and compared to the first generation techniques. These randomised controlled trials are 
summarized at the end of this paragraph.  
3.2.1 Balloon thermal ablation 
Balloon thermal ablation basically is a technique in which a balloon catheter attached to a 
central unit is placed in the uterine cavity. The balloon is then filled with a distension fluid 
and because of a constant pressure the balloon shapes the endometrial cavity as effective as 
possible. By heating and circulating the fluid for a specific time, endometrial ablation is 
accomplished . The balloon techniques differ in cervical dilatation, distension fluid, 
temperature of fluid, distension pressure and operating time. The main complications are 
postoperative nausea and uterine cramps, probably related to uterine distension and 
prostaglandin release. All available techniques are listed below. 
3.2.1.1 CavatermTM plus 
The original CavatermTMplus unit, consists of a computerised central unit and a single-use 
silicone balloon. The balloon size can be adjusted according to the size of the uterine 
cavity. The fluid used is 1.5% glycine, heated from the centre of the catheter to 75 degrees 
Celsius and constantly circulated throughout the system via a pump. The system monitors 
the pressure within the circuit and it is maintained between 220-240 mm Hg. The 
treatment time is 15 minutes and the depth of endometrial ablation is 6-8 mm. Cavaterm 
plus system uses a 5% dextrose solution and requires cervical dilatation only to 6 mm. The 
duration of treatment is 10 minutes and there is no need for pre-treatment of the 
endometrium. The device is portable and has a small diameter probe. To be effective, the 
intimate contact between the balloon and the endometrium is important. Patient 
satisfaction rate as recorded is 83% after two years, amenorrhea was achieved in 39% of 
the patients. (El Thouky, 2004).  
3.2.1.2 Thermachoice III  
Thermachoice ® comprises a single use balloon catheter, a connecting cable and a dedicated 
controller unit that is powered from a standard alternating current wall outlet. The outside 
diameter of the catheter is 5.5 mm and the heating element is incorporated in the balloon 
itself. After exposure of the cervix and the required dilation, the balloon-tipped catheter is 
passed through the cervical canal into the endometrial cavity. The surgeon uses a syringe to 
inflate the balloon with 5% dextrose and water to a predetermined pressure of 160 tot 180 
mm Hg. The dedicated controller unit is then activated, therby heating the element and the 
fluid. The target balloon temperature is 87 degrees Celsius and ablation time is about 8 
minutes. The depth of ablation is 4.5 mm. Patient satisfaction rate as registered is 95.9% after 
one year, amenorrhea is achieved in 15.2% of the patients, complimentory surgery was 
necessary in 33% of the patients after 5 years (Loffer, 2002).  
3.2.1.3 Thermablate® 
Thermablate®, an endometrial ablation system (EAS), consists of a light weight, reusable, 
hand-held treatment control unit with a single-use disposable catheter of 6 mm in diameter. 
Following insertion of the prelubricated balloon into the endometrial cavity, a glycerine 
solution is heated to 173 degrees Celsius and the pressure is automatically maintained at 180 
mm Hg for a treatment cycle of 2 minutes and 8 seconds. Tissue necrosis to a uniform depth 
of 4-5 mm. can be accomplished.  
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3.2.1.4 Menotreat ®  
MenoTreat® is a relatively new method, which is mainly used in the Scandinavian 
countries. The system consists of a disposable silicone catheter with a balloon (two possible 
sizes) and a control unit. The cervix is dilated to 8 mm for insertion of the 7 mm diameter 
catheter. The fluid, saline is heated to 85 degrees Celsius in the control unit and circulates 
from there through the catheter. The pressure is maintained at 200 mm Hg and the 
treatment time is 11 minutes.  
3.2.2 Free fluid endometrial ablation  
Endometrial ablation with HydroThermablator® (HTA) is based on the principle of 
circulating heated free fluid and is the only technique with hysteroscopic monitoring during 
the procedure. The device consists of a single use 7.8-mm sheath which is connected to a 
proprietary controller unit. The controller unit regulates the processes of uterine distension, 
creation of a closed circuit, fluid heating, and monitoring of temperature and circuit volume. 
The distending medium is normal saline drawn from a bag mounted on a attached, 
modified IV pole. After dilatation of the cervix and priming of the circuit, the telescope and 
sheath are placed transcervical into the endometrial cavity. After confirmation of 
intracavitary positioning, the microprocessor-controlled automated system is started. The 
tip of the endoscope and sheath are held at the level of the internal cervical OS. The process 
takes approximately 3 minutes to heat the fluid to 90 degrees Celsius. The hot fluid is 
maintained for10 minutes in the uterine cavity, after which it is allowed to cool down in one 
minute before removal of the device. Necrosis depth is about 3-4 mm. The process can be 
stopped at any time by the surgeon. If there is a loss of more than 10 mL of the distending 
medium either through the cervix or the fallopian tubes, the system stops the procedure 
automatically. To prevent leakage of hot fluid through the fallopian tubes the intra uterine 
pressure is kept below 55 mm Hg. Specific complications of this technique are perineal, 
vaginal and thigh burns when the hot fluid leaks from the cervix. The amenorrhea rate 
reported with the HydroThermablator was 53%, with decrease in menstrual bleeding in 94% 
of the patients treated. Patient satisfaction rate is high, 98% after 3 years and complementary 
surgery is necessary in about 11% of the patients (Goldrath, 2003).  
3.2.3 Microwave endometrial ablation 
There are two versions of the microwave endometrial ablation (MEA) device, one reusable 
and the other disposable. FemWave® comprises an 8 mm outside diameter probe attached 
through a reusable cable to a dedicated control module. The microwave frequency is 9.2 
GHz, power output 30 W, and the local tissue is heated to about 90 degrees Celsius, 
achieving a depth of tissue necrosis of about 5-6 mm. The probe also contains an 
integrated thermal coupling device that transmits information about adjacent tissue 
temperature to the control module. Activation and control of the device is entirely in the 
hands of the surgeon. Once the cervix is dilated, hysteroscopic imaging confirms 
intracavitary placement and after both the canal and cavity are confirmed to be intact, the 
microwave probe is inserted to the uterine fundus. When the measured temperature of 
the tissue around the probe reaches 30 degrees Celsius, the device is activated and the 
surgeon uses sweeping movements in the horizontal plane until a treatment temperature 
threshold of 80 degrees Celsius is reached. By gradually withdrawing the device the 
surgeon covers the entire endometrial surface. When the tip of the probe reaches the area 
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that approximates the location of the cervical channel, the device is deactivated and the 
probe is removed. Treatment time depends on cavity size and is usually about 2-4 
minutes. Endometrial curettage prior to MEA application is not recommended as it 
increases the risk of unrecognised uterine perforation and subsequent microwave-induced 
bowel damage. Patient satisfaction after 5 years is about 71%, and amenorrhea is achieved 
in 84% of patients after 5 years (Sambrook, 2010). 
3.2.4 Radiofrequency endometrial ablation 
NovaSure® is an ablation technique that uses impedance controlled bipolar radiofrequency 
(RF) for endometrial ablation. The system is based on a dedicated microprocessor-based 
control unit and a single use 7.2 outside diameter probe with a bipolar gold mesh electrode 
array located at the distal end. To detect a perforation of the myometrium, the probe 
contains a system for determining the integrity of the endometrial cavity based on injection 
of a fixed volume of CO2. After appropriate cervical dilatation, the electrode assembly is 
inserted transcervically and the electrode is deployed by retraction of an outer sleeve. The 
electrodes have a triangular shape that correspond with the surface of the uterine cavity. 
The surgeon then measures the intercornual distance using an indicator on the probe and 
enters this value together with the cavity length into the controller unit allowing the system 
to calculate the amount of power required. Before activation, the dedicated controller unit 
performs a so called uterine integrity test to exclude a perforation. After this RF energy is 
applied to the endometrial tissue and at the same time steam and carbonized debris is 
evacuated from the uterine cavity. This process results in electrosurgical vaporization and 
underlying desiccation in a relatively short time (90-120 seconds). The depth of vaporization 
and desiccation varies throughout the uterine cavity, less in the cornual areas and more in 
the other areas. The process is controlled by increasing tissue impedance of the adjacent 
desiccated tissue, shutting the system off when it exceeds 50 omega. Patient satisfaction rate 
of the Novasure® method is 92.8%. After one year, 41% of the patients reported amenorrhea 
and 88.3% with a satisfactory decrease in monthly menstrual bleeding. Complementary 
surgery is seen in 9.8% of patients after 5 years (Kleijn, 2008).  
3.2.5 Cryotherapy  
Cryotherapy was first used in 1967 but enthusiasm was restrained by reports of pelvic 
abscesses after this procedure. With the development of transcervical uterus sparing 
techniques for endometrial ablation, the principle of cryotherapy was revitalized resulting in 
a device called Her Option®. Destruction of the endometrium is achieved by freezing it to -
90 degrees Celsius. The device consists of a disposable 4.5 mm outside diameter probe 
attached to a handle and cable, which is connected to a dedicated controller unit. After 
exposure of the cervix, cervical dilation is performed if necessary, and the device is inserted 
into the uterine cavity. The surgeon activates the controller which super cools the tip of the 
probe to -90 degrees Celsius, resulting in a progressively expanding elliptical frozen zone 
involving both endometrium and myometrium. The size of this zone depends on the 
exposure time and can be monitored by the surgeon using transabdominal ultrasound. To 
cover all the endometrium usually 2 or 3 cycles, with a total treatment time of about 10 
minutes, are necessary. The depth of tissue necrosis is about 12 mm. Clinical outcomes 
shows a reduction in menstrual bleeding of 84.6%, with amenorrhea rates not well 
documented. Long term follow up shows a hysterectomy rate of about 7% and a reablation 
rate of 8.1% after 24 months (Townsend, 2003). 
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3.2.6 Endometrial laser intrauterine thermal therapy (ELITT) 
The ELITT diode laser system (Gynelase®) is a system that produces 830nm diode laser light 
through a flexible quartz fibre to an intrauterine device., This device is composed of three 
fibres that ensure circumferential diffusion of the active laser light inside the uterine cavity. 
The fibres adhere to the uterine walls and uniformly distribute the laser beam over the 
endometrium from the fundus to the isthmus of the uterine cavity. This procedure exploits 
the thermic and coagulative properties of the laser beam in a way that the poorly accessible 
cornual endometrium also can be ablated. The cervical canal is first dilated up to 7 mm, and 
the closed diffuser device is then introduced into the uterine cavity. When it reaches the 
fundus, the surgeon opens the lateral fibres, giving the system an inverted triangular shape 
that adapts to the uterine cavity. The laser is activated for 7 minutes in a continuous tissue 
exposure mode in three consecutive steps; distension fluid is not required for this 
procedure. Results of ELITT show an amenorrhea rate of 61% after 36 months and an overall 
patient satisfactory rate of 89%, re-intervention by hysterectomy is reported in 5% of the 
patients (Perino, 2004). 
3.2.7 Photodynamic therapy 
Photodynamic therapy for endometrial ablation (PEA), provides a photo oxidation-based, 
selective endometrial destruction, tested mainly in animal studies. There is only one 
human feasibility study executed (Degen, 2004). PEA was performed by injecting 5-
aminolevulinic acid (ALA) into the uterine cavity. After three to six hours a light dose of 
160J/cm3 at a wavelength of 635 nm was applied to the endometrial lining using a 
balloon-light diffuser. The light was fractionated in sequences of 5 minutes of illumination 
followed by gaps of 2 minutes. Bleeding patterns were significantly reduced 1-3 months 
after treatment, but this reduction was not significant after long term follow up. This 
technique is still in an experimental stage. 
3.2.8 Chemoablation 
With so called chemo ablation 95% trichloroacetate (TCA) is used to destroy the 
endometrium. This compound is also used in the treatment of papilloma warts. Before the 
procedure, patients receive non-steroidal anti-inflammatory drugs orally. Under local 
anaesthesia, with a paracervical block, a 3mm cannula must be inserted into the cervix. 
Through this cannula the volume of TCA needed is instilled into the uterine cavity. Leakage 
from the cervix is collected in a sponge. The treatment results were recorded both with and 
without pre-treatment with a GnRH analogue one month before surgery. Patient satisfactory 
after 1 year is 93.3% and 95.6%, respectively in the group without and with pre-treatment. 
Amenorrhea is accomplished in 31.1% and 26.7% in these groups and reduction of bleeding 
is reported in 68.9 and 66.7%, respectively (Kucuk, 2005). 
4. Randomized controlled trials 
Many studies have been performed over the last years, involving both first and second 
generation techniques. We have selected the most relevant randomized controlled trials 
with long term follow-up. The results are summarized in table with regard to patients 
satisfactory, amenorrhea rates, reintervention surgery rates and the main conclusions of 
the authors.  
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Study Satisfactory 
Amenorrhea 
Rate 
Reintervention 
surgery 
Conclusion 
Studies comparing 1st generation techniques with 2nd generation techniques. 
Sambrook, 
2009 
10 year follow 
up: 
- MEA  
- TCRE 
 
 
 
 
60% 
52% 
 
 
 
 
83% 
88% 
 
 
 
 
17% 
28% 
Both techniques achieve 
significant and comparable 
improvement in menstrual 
symptoms, health-related 
quality of life and high rates of 
satisfaction. With the known 
operative advantages, lower 
costs and fewer 
hysterectomies, it is clear that 
MEA is a more effective and 
efficient treatment for heavy 
menstrual loss than TCRE. 
Goldrath, 2003 
- HTA 
- Rollerball 
ablation 
 
98% 
97% 
 
53% 
46% 
 Endometrial ablation with the 
HTA is a safe, effective, and 
durable treatment of 
menorrhagia in a broad patient 
population. It offers advantages 
over RB by reducing 
anaesthesia requirements, 
reducing operating time, and 
eliminating risks of excessive 
fluid absorption, and is more 
easily learned. 
Studies comparing 2nd generation with 2nd generation techniques 
Kleijn, 2008 
5 year follow 
up.  
- Bipolar 
radiofrequency. 
- Thermal 
balloon 
  
 
 
48% 
 
32% 
 
 
 
9.8% 
 
12.6% 
At 5 years follow up, bipolar 
thermal ablation was superior 
over balloon ablation in the 
treatment of menorrhagia. 
Sambrook, 
2009,  
- MEA 
- Thermal 
balloon 
 
 
76% 
77% 
 
 
41% 
38% 
 Both treatments are acceptable 
to women, with high levels of 
satisfaction. Microwave is 
quicker to perform with faster 
hospital discharge. 
 
Table 2. Randomized controlled trials performed last years. 
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A large Cochrane Database review intensively studied and combined the studies comparing 
first and second generation techniques (Lethaby, 2009). The authors conclude that 
endometrial ablation offer a less invasive surgical alternative to hysterectomy. The 
conclusions of this review slightly favour the second generation techniques. Advantages 
were a shorter surgery time (15minutes), the use of local anaesthesia, and fewer 
complications like fluid overload, uterine perforation, cervical lacerations and 
haematometra. However, the second generation was associated with more equipment 
failure and patients were more likely to suffer from nausea, vomiting and uterine cramping 
postoperatively.  
4.1 Conclusion 
Main problem in comparing the first and second generation techniques is the heterogeneity 
of all studies. Especially, in the first generation, experience and skills of the surgeon are 
important cofounding factors. No significant differences are found in amenorrhoea rates 
and requirement for any additional surgery or hysterectomy between both generations. In 
general, one can say that with the introduction of the second generation the operation time 
is shorter, complications like fluid overload and perforation are reduced and the skills and 
experience of the surgeon has become less important.  
5. Factors affecting outcome of endometrial ablation 
The outcome of endometrial ablation regarding patients’ satisfaction , amenorrhea rates and 
side effects, is intensively studied. In this paragraph we will discuss the factors that possibly 
affect the outcome of endometrial ablation.  
5.1 Patient factors 
Patient characteristics are important to decide whether a treatment modality is suitable for 
an individual patient. There are not many studies reporting pre operative factors 
influencing the outcome of global endometrial ablation. Patient factors that could predict 
amenorrhea after endometrial ablation are: an age older than 45 years, uterine length less 
than nine centimetres and endometrial thickness less than four millimetres (El-Nashar, 
2009). Patient factors found to be prognostic for treatment failure are an age younger than 
45 years, parity of five or greater, prior tubal ligation and history of dysmenorrhoea (El-
Nashar, 2009). The role of leiomyomas in the outcome of endometrial ablation has not 
been established. Submucous leiomyomas increase the volume of menstrual bleeding by 
mechanisms that are, to date, not well understood. One of these mechanisms is probably 
the larger cross sectional area of endometrium of the uterine cavity. As a result, 
endometrial ablation is assumed to be successful in the treatment of women with 
myomas, but on the other hand, leiomyomas are also considered an important reason for 
treatment failure. Literature on this subject is not conclusive, and the presences of 
myomas has often been reason for exclusion. With the development of different new 
techniques it is expected that the presence of leiomyomas will not always be an exclusion 
factor for endometrial ablation, e.g. no evidence is found that the presence of leiomyomas 
is a predictive value for post operative amenorrhea rate or treatment failure (El-Nashar, 
2009).  
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5.2 Preoperative thinning of the endometrium 
Complete endometrial destruction is one of the most important determinants of treatment 
success. During the menstrual cycle endometrial thickness varies from as little as 1mm in the 
immediate postmenstrual phase to 10 mm or more in the late secretory phase. The techniques 
described have an ablation depth, ranging mostly from 4-6 mm. It is obvious that an 
endometrial thickness of 10 mm with a technique infiltration depth of 6 mm, is less effective. 
Therefore, thinning of the endometrium and planning of the surgery could contribute to a 
successful outcome. On the other hand, does pre-treatment with agents like GnRH analogues 
or Danazol add additional side effects and costs to any endometrial ablation procedure? A 
large Cochrane review was published in 2009. In this study the effect of pre-operative 
endometrial thinning before endometrial ablation was investigated. (Sowter, 2009).  
5.2.1 Gonadotrophin-releasing hormones analogues 
Down regulation of the receptors by Gonadotrophin- Releasing Hormones (GnRH) 
analogues results in a hypoestrogenic state leading to atrophic endometrium. Side effects 
of the treatment may be hot flushes, vaginal dryness, mood swings, headache, libido loss, 
difficulties in sleeping and weight changes. The use of GnRH analogues preoperatively 
showed a significant reduction in endometrial thickness on ultrasound and atrophic 
endometrial glands on histological examination (Donnez, 1997), This effect of GnRH 
analogues is larger compared to the effect of Danazol or preoperative admission of 
progestagens. Comparing hysteroscopic resection of the endometrium with or without 
GnRH, pre-treatment favours shorter duration of surgery, the surgery was easier to 
perform and a higher rate of amenorrhea 12 months postoperatively. There is no evidence 
that these results may be the same in patients treated with the second generation 
endometrial ablation techniques. Overall, the long-term effects of GnRH analogues as pre-
treatment are unclear. (Sowter, 2009). 
5.2.2 Danazol 
Danazol is a testosterone analogue, with anti-hormonal effect, resulting in a secondary 
decrease of LH and FSH with ovarian failure. Side effects are acne, greasy skin, stem 
changes, weight gain, libido loss. Danazol is more effective than no treatment in inducing 
atrophy in endometrial glands and reducing endometrial thickness as measured with 
ultrasound. Pre-treatment with Danazol does not lead to higher rate of amenorrhea, patient 
satisfaction or less women requiring further surgery, under patients undergoing first 
generation endometrial ablation or resection. Compared to the GnRH analogues, the effect 
of Danazol on thinning the endometrial lining is inferior. (Sowter, 2009).  
5.2.3 Progestagens 
Pre-treatment with progestagens does not lead to an adequate reduction of endometrial 
thickness or atrophy of the endometrial glands (Rich, 1995). The use of progestagens is not 
recommended at all pre-operatively except in case of a trial (Sowter, 2009).  
5.3 Surgical skills 
One of the reasons for the development of the second generation techniques are the long 
learning curve and advanced surgical skills necessary for an adequate hysteroscopic 
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resection of the endometrium. It is demonstrated that complication risk and treatment 
failure of the first generation techniques are much higher when the experience of the 
surgeon is limited to less than 100 procedures. (Overton, 1997). With the introduction of the 
second generation, the advanced operating skills have become less important without 
impairing treatment results or patients satisfaction (Lethaby, 2009). 
5.4 Conclusion 
Although pre-treatment with both GnRH analogues and Danazol results in thinning of the 
endometrial layer, they do not seem to offer any benefit regarding to treatment outcome, 
patients satisfaction or number of complications. The experience and surgical skills of the 
surgeon are important factors in the first generation hysteroscopic techniques. Specially, the 
presence of large myomas, the size of the uterus and the endometrial thickness seem to be a 
limitation for the use of the second generation techniques  
6. Complications 
With the development of first and second generation endometrial ablative techniques for 
treating heavy menstrual bleeding, its use expanded really fast during the last decades. 
Advantages of these therapy compared to hysterectomy are the shorter operation time, the 
shorter post operative period, the cost effectiveness and the lower morbidity and mortality 
compared to hysterectomy . However, both peri- and postoperative complications related to 
endometrial ablation are described.  
6.1 Perioperative complications 
Perioperative complications are strongly related to the experience of the surgeon and the 
technique used. In general, second generation techniques have a lower complication rate 
due to shorter operating time and compared to the hysteroscopic assisted methods relatively 
easy procedures. In the Mistletoe study (Overton, 1997), complications of more than 10000 
patients treated in the United Kingdom between 1993 and 1994 with endometrial resection, 
endometrial ablation by rollerball and laser, cryotherapy and radiofrequency ablation were 
registered. Most common complications with the first generation techniques are peri- or 
postoperative haemorrhage and uterine perforation. Haemorrhage was reported in 2.38% of 
the cases, ranging from 0.97% in case of roller ball alone to 3.53% with the combination of 
endometrial dissection and rollerball. Uterine perforation was reported in 1.48% of the cases. 
The experience of the surgeon with the technique used is the most important factor 
influencing the complication rate (Overton, 1997).  
6.2 Postoperative complications 
Post operative complications diagnosed after treatment or after discharge from the hospital 
include heavy bleeding, abdominal pain, urinary retention, hypotension, nausea, vomiting, 
bradycardia, chest pain, urinary tract infection, haematurie, hyponatraemia, pyrexia, deep 
venous thrombosis and fluid overload syndrome. These complications are rare and only 
small numbers are recorded. Overall percentages reported range from 0.77%-2.86% of the 
cases, depending on the technique used (Overton, 1997). The fluid overload syndrome is a 
well known and possible fatal complication. Absorption of distension fluid could cause 
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hyponatremia with mild symptoms like nausea, but also serious consequencess like seizures 
and even death due to cerebral oedema. The incidence of fluid overload syndrome is 
associated with the duration of surgery. In general, the complications as registered in the 
Mistletoe study are more likely to occur after the first generation techniques. Complications 
as nausea, vomiting and uterine cramping are more related to the second generation 
techniques (Lethaby, 2009).  
6.3 Late onset complications 
Complications diagnosed more than six weeks postoperatively are endometritis, 
septicaemia, pneumonia, peritonitis, pulmonary embolism and surgery for bowel repair. 
This group of complications are recorded in 1.25% of the cases (Overton, 1997). A cervical or 
lower uterine segment stenosis after endometrial ablation can cause a secondary to bleeding 
in the uterine cavity. Symptoms are amenorrhea in concert with cyclic lower abdominal or 
pelvic pain. The complaints usually start months and sometimes years after the procedure. 
Treatment modalities are cervical dilatation, hysteroscopic drainage or hysterectomy. Tubal 
sterilisation is a risk factor for hysterectomy after endometrial ablation. Abdominal pain is 
caused by bleeding from persistent or regenerating cornual endometrium causing a focal 
cornual hematometra with retrograde bleeding into an occluded fallopian tube. This 
syndrome is called post ablation tubal sterilisation syndrome (PATSS). The exact incidence 
of central hematometra and PATSS is unknown but it is estimated around 10% of the 
patients . (McCausland, 2007). 
7. Endometrial ablation and pregnancy 
Approximately, one in every five premenopausal women refers to a health care 
professional because of heavy menstrual bleeding. Because endometrial ablation is not 
reliable as contraceptive, all these women are at risk to become pregnant after the 
treatment. In two large studies including more than nine thousand patients the pregnancy 
rate after ablation was 0.68% (Pugh, 2000; Roy and Mattox, 2002). Obviously, when none 
of the patients had used contraceptives this percentage should have been higher. 
Pregnancy after endometrial ablation is associated with a number of complications and is 
therefore considered to be a contraindication.  
The literature on complications during pregnancy is limited to case reports. Miscarriage is 
reported in 21% of the pregnancies after ablation (Hare, 2005). Although ectopic 
pregnancies are described it is unclear whether the number is increased after endometrial 
ablation. With an ongoing pregnancy the risk for pre term delivery (31%), pre term labour 
(21%), pre term rupture of membranes (17%), intra uterine growth restriction (12%) 
malpresentations (39%), and pathological placentation (17%) are all increased. The latter is 
notorious, leading to a wrong implantation of the placenta in the uterine wall with a high 
rate of hysterectomy after caesarean section (Hare, 2005). Moreover, the diagnosis in these 
cases is difficult because classical ultrasonsgraphic appearances of this abnormality may 
not be present after ablation. Therefore, patients should be counselled carefully, an active 
wish for children must be excluded and additional contraceptive methods are necessary 
after the endometrial ablation. If a patient becomes pregnant, close follow up is advised 
with monitoring of growth and placentation.  
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Because many patients do not prefer oral contraceptives or a levonorgestrel device after 
endometrial ablation, the procedure is frequently combined with laparoscopic sterilisation. 
Recently, the first reports of the combined approach of endometrial ablation and 
hysteroscopic sterilisation are published. These studies demonstrate that hysteroscopic 
essure® sterilisaton after both radiofrequency and balloon endometrial ablation is feasible 
and safe. Although it is attractive to combine these minimal invasive procedures a serious 
concern is the reliability of the hysterosalpingography (HSG) as confirmation of the 
sterilisation. In about 26% tubal occlusion can not be determined by HSG because of severe 
uterine synechiae, probably caused by the endometrial ablation (Detollenaere, 2011). 
Whether or not endometrial ablation can safely be performed after an earlier hysteroscopic 
sterilisation remains to be established. 
8. Endometrial ablation and endometrial cancer 
Endometrial carcinoma is the most common gynaecologic malignant disease with a 
prevalence worldwide of 1/1000. Because an endometrial carcinoma is mostly diagnosed 
in an early stage , FIGO stage 1 (73%) or stage II (10%) the five year survival rates are 
high, for both stages 91%. The risk for endometrial carcinoma increases between 50-70 
years and is 8- fold higher in postmenopausal women. Approximately 50% of the 
endometrial cancers occur in women with associated risk factors like unopposed estrogen 
stimulation, obesity, diabetes mellitus, chronic anovulation, hypertension and histological 
complex atypical endometrial hyperplasia or adenomatous hyperplasia (Bakarat, 2009). 
The most frequent first symptom of endometrial cancer is post- menopausal loss of blood. 
As endometrial ablation is a relatively new therapy with a variety of techniques, data on 
the incidence of endometrial cancer after endometrial ablation are lacking. Most cases are 
reported after a first generation technique. It is suggested that the incidence of 
endometrial cancer after ablation is reduced in case of maximal destruction of the 
endometrium. However, some evidence suggests that incidence of endometrial cancer is 
unchanged, after EA with first generation techniques (Neuwrith, 2004). It is unclear 
whether endometrial cancer originates from islands of regenerated endometrium below 
the basal layer or from adenomyosis. The diagnosis of this type of malignancy may be 
delayed after ablation because adhesions or scars could mask the symptoms of the 
disease. In case of post-menstrual bleeding after ablation ultrasound and hysteroscopy 
can be difficult to perform because of the anatomical distortion of the uterine cavity. 
(Jarvela, 2002; Luo, 1999) Theoretically, in patients at risk for standard operative therapy, 
endometrial ablation could play a role in the treatment of endometrial neoplasia or 
cancer. Whether this treatment modality is a serious option requires further study.  
9. Conclusion 
In this chapter we discussed the most commonly used methods for endometrial ablation 
and gave a historic overview of these techniques. For today the “gold standard” is still 
transcervical endometrial resection with rollerball ablation throughout the world. 
However, the second generation techniques are developing fast and it is likely that they 
will replace the first generation. It is important to continue research to establish optimal 
endometrial ablative therapy to improve amenorrhoea rates, patients satisfaction and 
reduce the need for hysterectomy. 
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